Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Photodynamic procedures in urology]

D Jocham1

  • 1Klinik für Urologie, Medizinischen Universität zu Lübeck.

Der Urologe. Ausg. A
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Photodynamic therapy (PDT) is effective for bladder cancer. Further clinical trials are needed to confirm the benefits of photodynamic fluorescence diagnosis (PDD) using delta-aminolevulinic acid (ALA).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Focal dose escalation in the treatment of prostate cancer : Long-term results of HDR brachytherapy].

Der Urologe. Ausg. A·2016
Same author

[Implementation of a scale on stone baskets].

Aktuelle Urologie·2014
Same author

[Accidental destruction of stone trapping baskets: new knowledge on the interaction of baskets, stone trapping devices, guide wires and lithotriptors - a brief review].

Aktuelle Urologie·2013
Same author

[The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Der Urologe. Ausg. A·2013
Same author

[Aspects of bladder cancer].

Der Urologe. Ausg. A·2012
Same author

[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy].

Der Urologe. Ausg. A·2012
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Area of Science:

  • Oncology
  • Photochemistry

Context:

  • Photodynamic therapy (PDT) is an established treatment for carcinoma in situ of the urinary bladder.
  • Existing pilot studies lack comparability due to variations in photosensitizers, irradiation methods, and dosages.
  • Photodynamic fluorescence diagnosis (PDD) using delta-aminolevulinic acid (ALA) offers a clinically feasible diagnostic approach.

Purpose:

  • To address the lack of standardized data in current photodynamic therapy research for bladder cancer.
  • To highlight ongoing research in developing more selective photosensitizers and optimizing irradiation techniques.
  • To emphasize the need for rigorous clinical trials to validate the efficacy of photodynamic fluorescence diagnosis (PDD).

Summary:

  • Current research focuses on basic PDT principles, selective photosensitizer development, and irradiation optimization for bladder cancer.

Related Experiment Videos

  • Prospective randomized clinical trials are underway, particularly for superficial bladder cancer.
  • Delta-aminolevulinic acid (ALA)-based photodynamic fluorescence diagnosis (PDD) shows potential but requires controlled trials for efficacy confirmation.

    • Impact:

    • Standardized PDT protocols could improve treatment outcomes for bladder carcinoma in situ.
    • Advancements in photosensitizers and irradiation may lead to more targeted and effective bladder cancer therapies.
    • Validated PDD could enhance early detection and management of superficial bladder cancers.